位置:首页 > 蛋白库 > TGL3_YEAST
TGL3_YEAST
ID   TGL3_YEAST              Reviewed;         642 AA.
AC   P40308; D6W0E0;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   03-AUG-2022, entry version 160.
DE   RecName: Full=Triacylglycerol lipase 3;
DE            EC=3.1.1.3 {ECO:0000269|PubMed:12682047};
DE   AltName: Full=Lipase 3;
GN   Name=TGL3; OrderedLocusNames=YMR313C; ORFNames=YM9924.05C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S., Jagels K.,
RA   Lye G., Moule S., Odell C., Pearson D., Rajandream M.A., Rice P.,
RA   Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII.";
RL   Nature 387:90-93(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-174.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7918444; DOI=10.1021/bi00206a028;
RA   Heinemeyer W., Troendle N., Albrecht G., Wolf D.H.;
RT   "PRE5 and PRE6, the last missing genes encoding 20S proteasome subunits
RT   from yeast? Indication for a set of 14 different subunits in the eukaryotic
RT   proteasome core.";
RL   Biochemistry 33:12229-12237(1994).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10515935; DOI=10.1128/jb.181.20.6441-6448.1999;
RA   Athenstaedt K., Zweytick D., Jandrositz A., Kohlwein S.D., Daum G.;
RT   "Identification and characterization of major lipid particle proteins of
RT   the yeast Saccharomyces cerevisiae.";
RL   J. Bacteriol. 181:6441-6448(1999).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12682047; DOI=10.1074/jbc.m302577200;
RA   Athenstaedt K., Daum G.;
RT   "YMR313c/TGL3 encodes a novel triacylglycerol lipase located in lipid
RT   particles of Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 278:23317-23323(2003).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   SER-237.
RX   PubMed=16267052; DOI=10.1074/jbc.m508414200;
RA   Kurat C.F., Natter K., Petschnigg J., Wolinski H., Scheuringer K.,
RA   Scholz H., Zimmermann R., Leber R., Zechner R., Kohlwein S.D.;
RT   "Obese yeast: triglyceride lipolysis is functionally conserved from mammals
RT   to yeast.";
RL   J. Biol. Chem. 281:491-500(2006).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20016004; DOI=10.1091/mbc.e09-09-0775;
RA   Rajakumari S., Daum G.;
RT   "Janus-faced enzymes yeast Tgl3p and Tgl5p catalyze lipase and
RT   acyltransferase reactions.";
RL   Mol. Biol. Cell 21:501-510(2010).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21820081; DOI=10.1016/j.bbalip.2011.07.015;
RA   Grillitsch K., Connerth M., Kofeler H., Arrey T.N., Rietschel B.,
RA   Wagner B., Karas M., Daum G.;
RT   "Lipid particles/droplets of the yeast Saccharomyces cerevisiae revisited:
RT   lipidome meets proteome.";
RL   Biochim. Biophys. Acta 1811:1165-1176(2011).
RN   [10]
RP   ACYLTRANSFERASE MOTIF.
RX   DOI=10.1007/s11515-011-1142-6;
RA   Grillitsch K., Daum G.;
RT   "Triacylglycerol lipases of the yeast.";
RL   Front. Biol. 6:219-230(2011).
RN   [11]
RP   ACTIVITY REGULATION.
RX   PubMed=23673660; DOI=10.1074/jbc.m113.459610;
RA   Schmidt C., Athenstaedt K., Koch B., Ploier B., Daum G.;
RT   "Regulation of the yeast triacylglycerol lipase Tgl3p by formation of
RT   nonpolar lipids.";
RL   J. Biol. Chem. 288:19939-19948(2013).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=24868093; DOI=10.1194/jlr.m050229;
RA   Currie E., Guo X., Christiano R., Chitraju C., Kory N., Harrison K.,
RA   Haas J., Walther T.C., Farese R.V. Jr.;
RT   "High-confidence proteomic analysis of yeast lipid droplets identifies
RT   additional droplet proteins and reveals connections to dolichol synthesis
RT   and sterol acetylation.";
RL   J. Lipid Res. 55:1465-1477(2014).
CC   -!- FUNCTION: Lipid particle-localized triacylglycerol (TAG) lipase. The
CC       lipid droplet/particle is a lipid storage compartment which serves as a
CC       depot of energy and building blocks for membrane lipid biosynthesis.
CC       Involved in the mobilization of the non-polar storage lipids
CC       triacylglycerols (TAGs) from lipid particles by hydrolysis of TAGs,
CC       releasing and supplying specific fatty acids to the appropriate
CC       metabolic pathways (PubMed:10515935, PubMed:12682047, PubMed:16267052).
CC       Also catalyzes the acylation of lysophosphatidic acid (LPA). Important
CC       for efficient sporulation, but rather through its acyltransferase than
CC       lipase activity (PubMed:20016004). {ECO:0000269|PubMed:10515935,
CC       ECO:0000269|PubMed:12682047, ECO:0000269|PubMed:16267052,
CC       ECO:0000269|PubMed:20016004}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3;
CC         Evidence={ECO:0000269|PubMed:12682047};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12045;
CC         Evidence={ECO:0000305|PubMed:12682047};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-
CC         octadecenoate + di-(9Z)-octadecenoylglycerol + H(+);
CC         Xref=Rhea:RHEA:38575, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:53753, ChEBI:CHEBI:75945;
CC         Evidence={ECO:0000269|PubMed:16267052, ECO:0000269|PubMed:20016004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38576;
CC         Evidence={ECO:0000305|PubMed:16267052, ECO:0000305|PubMed:20016004};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=di-(9Z)-octadecenoylglycerol + H2O = (9Z)-octadecenoate + (9Z-
CC         octadecenoyl)-glycerol + H(+); Xref=Rhea:RHEA:47868,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:75937, ChEBI:CHEBI:75945;
CC         Evidence={ECO:0000269|PubMed:16267052};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47869;
CC         Evidence={ECO:0000305|PubMed:16267052};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + a 1-acyl-sn-glycero-3-
CC         phosphoethanolamine = 1-acyl-2-(9Z)-octadecenoyl-sn-glycero-3-
CC         phosphoethanolamine + CoA; Xref=Rhea:RHEA:37731, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:64381, ChEBI:CHEBI:75238;
CC         Evidence={ECO:0000269|PubMed:20016004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37732;
CC         Evidence={ECO:0000305|PubMed:20016004};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphoethanolamine + hexadecanoyl-CoA =
CC         1-acyl-2-hexadecanoyl-sn-glycero-3-phosphoethanolamine + CoA;
CC         Xref=Rhea:RHEA:37767, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:75265;
CC         Evidence={ECO:0000269|PubMed:20016004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37768;
CC         Evidence={ECO:0000305|PubMed:20016004};
CC   -!- ACTIVITY REGULATION: Loses its lipolytic activity in cells lacking
CC       nonpolar lipids. {ECO:0000269|PubMed:23673660}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=19 uM for 1-acyl-sn-glycero-3-phosphoethanolamine
CC         {ECO:0000269|PubMed:20016004};
CC         KM=18 uM for (9Z)-octadecenoyl-CoA {ECO:0000269|PubMed:20016004};
CC         Vmax=46.26 nmol/min/mg enzyme towards 1-acyl-sn-glycero-3-
CC         phosphoethanolamine {ECO:0000269|PubMed:20016004};
CC         Vmax=44.25 nmol/min/mg enzyme towards (9Z)-octadecenoyl-CoA
CC         {ECO:0000269|PubMed:20016004};
CC   -!- SUBCELLULAR LOCATION: Lipid droplet {ECO:0000269|PubMed:10515935,
CC       ECO:0000269|PubMed:12682047, ECO:0000269|PubMed:21820081,
CC       ECO:0000269|PubMed:23673660, ECO:0000269|PubMed:24868093}.
CC       Note=Partially retained in the endoplasmic reticulum in cells lacking
CC       triacylglycerols. {ECO:0000269|PubMed:23673660}.
CC   -!- DISRUPTION PHENOTYPE: A double deletion of TGL3 and TGL4, the 2 major
CC       TGA lipases, leads to fat yeast, rendering growing cells unable to
CC       degrade triglycerides. {ECO:0000269|PubMed:16267052}.
CC   -!- MISCELLANEOUS: Present with 3210 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z54141; CAA90831.1; -; Genomic_DNA.
DR   EMBL; L34347; AAA53543.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA10214.1; -; Genomic_DNA.
DR   PIR; S59306; S59306.
DR   RefSeq; NP_014044.1; NM_001182824.1.
DR   AlphaFoldDB; P40308; -.
DR   BioGRID; 35493; 88.
DR   DIP; DIP-5641N; -.
DR   IntAct; P40308; 3.
DR   MINT; P40308; -.
DR   STRING; 4932.YMR313C; -.
DR   SwissLipids; SLP:000000052; -.
DR   SwissLipids; SLP:000000671; -.
DR   SwissLipids; SLP:000000678; -.
DR   iPTMnet; P40308; -.
DR   MaxQB; P40308; -.
DR   PaxDb; P40308; -.
DR   PRIDE; P40308; -.
DR   EnsemblFungi; YMR313C_mRNA; YMR313C; YMR313C.
DR   GeneID; 855361; -.
DR   KEGG; sce:YMR313C; -.
DR   SGD; S000004930; TGL3.
DR   VEuPathDB; FungiDB:YMR313C; -.
DR   eggNOG; KOG2214; Eukaryota.
DR   GeneTree; ENSGT00940000176365; -.
DR   HOGENOM; CLU_009031_5_0_1; -.
DR   InParanoid; P40308; -.
DR   BioCyc; MetaCyc:G3O-32977-MON; -.
DR   BioCyc; YEAST:G3O-32977-MON; -.
DR   PRO; PR:P40308; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   RNAct; P40308; protein.
DR   GO; GO:0005811; C:lipid droplet; IDA:SGD.
DR   GO; GO:0071618; F:lysophosphatidylethanolamine acyltransferase activity; IDA:SGD.
DR   GO; GO:0004806; F:triglyceride lipase activity; IDA:SGD.
DR   GO; GO:0007114; P:cell budding; IMP:SGD.
DR   GO; GO:0044255; P:cellular lipid metabolic process; IMP:SGD.
DR   GO; GO:0019433; P:triglyceride catabolic process; IMP:SGD.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR002641; PNPLA_dom.
DR   InterPro; IPR021771; Triacylglycerol_lipase_N.
DR   Pfam; PF11815; DUF3336; 1.
DR   Pfam; PF01734; Patatin; 1.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   PROSITE; PS51635; PNPLA; 1.
PE   1: Evidence at protein level;
KW   Hydrolase; Lipid degradation; Lipid droplet; Lipid metabolism;
KW   Reference proteome.
FT   CHAIN           1..642
FT                   /note="Triacylglycerol lipase 3"
FT                   /id="PRO_0000203356"
FT   DOMAIN          204..392
FT                   /note="PNPLA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   REGION          471..502
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           235..239
FT                   /note="GXSXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           298..303
FT                   /note="HXXXXD acyltransferase motif"
FT                   /evidence="ECO:0000305|PubMed:20016004, ECO:0000305|Ref.10"
FT   ACT_SITE        237
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   ACT_SITE        403
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q12043"
FT   MUTAGEN         237
FT                   /note="S->A: Abolishes TAG lipolytic activity."
FT                   /evidence="ECO:0000269|PubMed:16267052"
FT   CONFLICT        96
FT                   /note="A -> P (in Ref. 3; AAA53543)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        100
FT                   /note="R -> P (in Ref. 3; AAA53543)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   642 AA;  73613 MW;  A5AE059EF65465D1 CRC64;
     MKETAQEYKV SAVIPTLLKN WILRVVYATL DHIPPFVWEI LHVITDIYFF WVQKLINYVR
     PHSRVIYYNA IKKLDECDTY QMWCQQASVV DEITGANLWR RNFFSRRYDF NSVIEQYSIL
     ENMLREEKYD VVKEKFSTTG PCMLRNFAGI GDKKLFTKSL MGTKLLIEQY LTRILEGLDI
     LNNQTLTPTS FFQRCKLSLG TTALILQGGS LFGLFHLGVI RGLLLQDLMP NIISGSSMGA
     CVASLFGCLS NEQLKQLLTD DNLLNIIKND VDLLKSCGYG NLEQHLNLGT LIQNLIHHGY
     SQDVYLFIRF VMKYIVKEKT FEEVYQITGK VFNIVIHPTD KSCPNLLNYV TTPNVLIKSA
     IECSLGSGVI SEDTSLLCKN LENEIEPFLN INKNKQVKFL TPENANNPSI TESPYTRLTE
     LFNVNNFIVS LARPYLAPLV VNDLKHEIKT SKYYYYKHYP NMPPINANTV RKTQRSSSQS
     PIKAGTVEDL EPEPLMSPVP PSSAVNDSAE YIIPELGIPQ LNFTEMEPLA FKFKYHLERK
     LKNIATMEFR HRMEVLDNLG LLCSLIKRLI IDEKTPRSAT EIAVVPRMKS LSLTRIIEGQ
     LNNIPYWIKS GERSTWPALA LIKTRCAVEF KLDDIIRARR SR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024